Latest Research And Development News

Page 15 of 115
Energy Action Limited (ASX:EAX) expanded its contracted forward revenue and cash pipeline in FY2026, but the growth was not yet visible in earnings. Revenue was broadly flat while net profit fell 78% and EBITDA declined 27%.
Victor Sage
Victor Sage
25 Sept 2026
Latrobe Magnesium has moved its demonstration plant into the final installation stage for magnesium metal, but its annual report flags a material uncertainty over whether the loss-making group can continue as a going concern. The company had $1.09 million in cash at 30 June and has since secured an $8.5 million equity raising to fund commissioning and corporate costs.
Victor Sage
Victor Sage
25 Sept 2026
Adisyn has moved closer to commercialising its graphene platform after independently verified sub-300°C deposition, a US patent allowance and a new defence technology arm. The progress came alongside a A$7.83 million statutory loss, A$4.47 million in operating cash outflows and a heavily judgement-based A$42.1 million technology asset.
Sophie Babbage
Sophie Babbage
24 Sept 2026
Immuron delivered record FY26 sales, a narrower loss and a much stronger cash balance, while shifting clinical development towards commercial partners. The annual report also flags a material weakness in inventory controls and confirms that IMM-529 remains dependent on a future licensing deal.
Victor Sage
Victor Sage
24 Sept 2026
Legacy Minerals enters FY2027 with a larger Mt Carrington resource, a positive preliminary development study and fresh drilling underway, but the proposed mine still requires substantial funding. The ASX-listed explorer reported a A$1.85 million FY2026 loss and held A$6.07 million in cash at year-end.
Maxwell Dee
Maxwell Dee
24 Sept 2026
PaySauce has moved its Global Payroll Platform from development into commercial operation in Australia, while first-quarter FY27 ARR rose 8% to $9.5 million. The expansion is supported by a stronger cash position, but higher customer acquisition costs and lower profitability leave execution firmly in focus.
Victor Sage
Victor Sage
24 Sept 2026
International Graphite has arranged approximately $1.5 million in non-dilutive finance with National Australia Bank to fund construction of its Collie graphite processing facility. The project remains targeted for production building completion in Q2 2027, but the funding adds future repayment obligations as the company moves closer to commissioning.
Victor Sage
Victor Sage
24 Sept 2026
BluGlass has agreed an A$8.0 million R&D-backed loan with Rockford, refinancing its existing Radium facility and adding about A$5.5 million of liquidity. The funding gives the laser developer more room to scale, but carries a 16.5% interest rate and repayment obligations tied to future tax refunds.
Victor Sage
Victor Sage
23 Sept 2026
PainChek grew recurring revenue, implemented licences and customer sites in FY2026, but its $8.94 million loss and $9.24 million operating cash outflow prompted an explicit going-concern warning from its auditor. The company is now betting that US deployments and a sharper commercial focus can convert market access into cash-generating growth.
Victor Sage
Victor Sage
23 Sept 2026
Orbit Resources enters FY2027 with a 17.52Mt Lewis Ponds resource, a preliminary study pointing to a A$481 million pre-tax NPV and a new polymetallic sulphide discovery outside the existing resource. The gains come with familiar junior-miner constraints: a A$3.49 million annual loss, A$3.69 million in cash and further funding still required.
Maxwell Dee
Maxwell Dee
23 Sept 2026
Booster Innovation Fund has invested $200,000 in TheiaNova, a University of Auckland spinout developing a self-administered eye drop for keratoconus. The seed-stage bet accounts for 0.76% of BIF’s portfolio, keeping the exposure modest while adding an early biotechnology asset.
Ada Torres
Ada Torres
22 Sept 2026
Latrobe Magnesium has secured A$8.5 million in equity funding to complete its Latrobe Valley demonstration plant and advance a proposed South Carolina magnesium project. The raising gives the company near-term funding certainty, but also brings further dilution and leaves the larger US development dependent on future capital.
Maxwell Dee
Maxwell Dee
22 Sept 2026

Browse the archive

Full archive